share_log

Entrada Therapeutics(TRDA.US) Director Buys US$20,793.93 in Common Stock

moomoo News ·  Apr 1 17:12

$Entrada Therapeutics (TRDA.US)$ Director KIM PETER S purchased 1,512 shares of Common Stock on Mar 28, 2024 at an average price of $13.7526 for a total value of $20,793.93.

1712005957911455949.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment